Home - Clinical Trials Arena
网页Perimeter completes enrolment for AI-assisted breast imaging trial. The primary endpoint results from the trial are expected by the end of the year and will be used to support an FDA approval for the OCT B-Series device. More themes.
Gilead’s lenacapavir: HIV prospects strongest in long-acting …
网页2021年8月25日 · Gilead’s lenacapavir will find its strongest niche as a long-acting HIV combination treatment, experts said. Manasi Vaidya August 25, 2021. Gilead announced a collaboration with Merck in March to study lenacapavir with islatravir, a nucleoside reverse transcriptase translocation inhibitor (NRTTI), which is also a new drug class in HIV.
Promising future for precision medicine thanks to AI, biomarkers …
网页2023年10月24日 · At the same time, the cell therapy market is also expected to surge, with a predicted forecast of over $52bn by 2029, up from nearly $3bn in 2022, according to GlobalData. Precision medicine trials have always been oncology-focused due to the mechanism of action (MoA) of most candidates, targeting and killing T-cells.
AstraZeneca kick-starts Phase III COPD trial for Breztri
网页2024年3月14日 · The Phase III trial will evaluate the effect of AstraZeneca’s triple-combination inhaled therapy Breztri on the reduction of cardiopulmonary events in COPD. Phalguni Deswal March 14, 2024. Breztri is a fixed-dose combination of a corticosteroid (budesonide), a long-acting muscarinic antagonist (glycopyrronium) and a long-acting …
Care Access Research and AstraZeneca partner for Covid-19 trial
网页2021年1月27日 · Decentralised research organisation (DRO) Care Access Research has collaborated with AstraZeneca to speed up the Phase III STORM CHASER clinical trial in the US assessing the latter’s long-acting monoclonal antibody (LAAB) combination, AZD7442, for preventing Covid-19. Vishnu Priyan January 27, 2021. The trial will have …
Top Ongoing mRNA Herpes Vaccine Trials - Clinical Trials Arena
网页2023年2月2日 · Pfizer and Moderna eye seasonal influenza. The two largest mRNA vaccine trials with readouts in 2023 are for seasonal influenza. First up, Moderna’s 6,102-patient, Phase III trial of mRNA-1010 (NCT05415462) has immunogenicity data expected in Q1 2023. The trial is testing mRNA-1010 against an active comparator vaccine, with primary …
Changing primary endpoints in clinical trials: proceed with caution
网页2024年2月15日 · Experts suggest taking caution when changing primary endpoints in active cancer clinical trials. Justine Ra February 15, 2024. The FDA encourages sponsors considering design changes to a registration trial to engage with the responsible Oncology Review Division. Credits: Andrii Yalanskyi/Shutterstock.com.
Obesity: Six trials to watch over the next 12 months
网页Abigail Beaney June 30, 2023. Here are some trials for obesity medications to watch over the next 12 months. Image credit: Zdenek Macat / Getty Images. The approval of Novo Nordisk ’s Wegovy in 2021 catapulted the landscape of obesity medications as companies race to develop other drugs which can provide higher levels of efficacy. Free ...
Oral Covid vaccine: can Vaxart overcome clinical trial obstacles?
网页2021年11月24日 · Vaxart’s Covid-19 vaccine tablet has a coating that allows it to withstand the low pH in the stomach. Credit: Vaxart. Vaxart is aiming to be a vital player in boosting vaccination rates with its oral Covid-19 vaccine. There is still unmet need, with only 53% of the world’s population receiving at least one dose of a Covid-19 vaccine.
OLINVYK (oliceridine) for the Treatment of Acute Pain
网页2020年8月26日 · OLINVYK™ (oliceridine) is a new chemical agent indicated for the treatment of acute pain in adults for whom the available treatments are ineffective. OLINVYK will be available as an intravenous injection with a recommended demand dose of 0.35mg, with a six-minute lock-out. The drug was developed by Trevena, which plans to make …
- 某些结果已被删除